By understanding how they work, their benefits and potential side effects, you can make an informed decision that suits your lifestyle needs
J Endocrinol 2014;221:T31T41.ArticlePubMed 105
Credit: AI Generated Image Updated Jun 10, 2026 | 09:00 PM IST Summary AstraZenecas oral GLP-1 pill, elecoglipron, lowered blood sugar and reduced body weight by 10.5% in a Phase 2b diabetes trial, highlighting growing potential for injection-free diabetes and obesity treatments.
Negative geotaxis showed no significant differences, consistent with variability described by (Motz and Alberts 2005)
Altogether, 70.1 million Americans currently are enrolled in Medicare, the federal government health insurance program for adults ages 65 and older